Lauren M. Sabella, Executive VP-Commercial Dvlpmnt at ACORDA THERAPEUTICS INC (ACOR), sold 8,797 shares at $31.81 ($280K) on 2013-12-05, disclosed to the SEC on 2013-12-09.
Scheduled sale ($280k) by Executive VP-Commercial Dvlpmnt under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-21 | $210K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |